Skip to Main Content

Paper Details

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.
Nat Commun
35
2021
AR, AR/MYC binding sites, Androgen, Androgen receptor, H3K27, MYC, MYC promoter, MYC super-enhancer, PCAT1 gene, PCa, androgen, castration-resistant PCa, developmental super-enhancer, functional enhancers, multiple genes, patients, prostate cancer
Author NameAffiliation
Haiyang GuoThe Second Hospital, Cheeloo College of Medicine, Shandong University
Haiyang GuoShandong Engineering & Technology Research Center for Tumor Marker Detection
Haiyang GuoShandong Provincial Clinical Medicine Research Center for Clinical Laboratory
Adam G SowalskyNational Cancer Institute, National Institutes of Health
Mark M PomerantzDana Farber Cancer Institute, Harvard Medical School
Mark M PomerantzDana Farber Cancer Institute, Harvard Medical School
Matthew L FreedmanDana Farber Cancer Institute, Harvard Medical School
Matthew L FreedmanThe Eli and Edythe L. Broad Institute
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Matthew L FreedmanDana Farber Cancer Institute, Harvard Medical School
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Matthew L FreedmanThe Eli and Edythe L. Broad Institute
Housheng Hansen HeUniversity of Toronto
Housheng Hansen HePrincess Margaret Cancer Center, University Health Network
Steven P BalkBeth Israel Deaconess Medical Center and Harvard Medical School
  • 1 - 15

Datasets